Correlation Between Aerovate Therapeutics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Viridian Therapeutics, you can compare the effects of market volatilities on Aerovate Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Viridian Therapeutics.
Diversification Opportunities for Aerovate Therapeutics and Viridian Therapeutics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aerovate and Viridian is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Viridian Therapeutics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.12 times more return on investment than Viridian Therapeutics. However, Aerovate Therapeutics is 1.12 times more volatile than Viridian Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 218.00 in Aerovate Therapeutics on August 28, 2024 and sell it today you would earn a total of 50.00 from holding Aerovate Therapeutics or generate 22.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Viridian Therapeutics
Performance |
| Timeline |
| Aerovate Therapeutics |
| Viridian Therapeutics |
Aerovate Therapeutics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Viridian Therapeutics
The main advantage of trading using opposite Aerovate Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
| Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. HCW Biologics | Viridian Therapeutics vs. Scpharmaceuticals | Viridian Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |